 Med. 2009;51:564 -577) 
M
ental disorders have been identified as the leading cause of disability in the United States and Canada for persons aged 15 to 44.
1 Anxiety disorders are the most prevalent class of mental disorders, with an estimated annual prevalence rate of 18.1% and lifetime prevalence rate of 28.8%. 2, 3 Anxiety disorders are often comorbid with depression 4, 5 ; an estimated 58% of those diagnosed with depression have a diagnosis for an anxiety disorder and 85% have symptoms of anxiety. 5 The 12-month and lifetime prevalence rates for mood disorders-major and minor depression and bipolar disorderswere estimated to be 9.5% and 20.8%, respectively, making these disorders the most prevalent class of mental disorders apart from anxiety disorders. 2, 3 Impulse control disorders-including attention deficit/ hyperactivity disorder (ADHD)-have an estimated prevalence rate of 8.9% annually and 24.8% over a lifetime. 2, 3 In addition, patients diagnosed with ADHD frequently have comorbid diagnoses for anxiety disorders, depression, and other impulse control disorders. 6 Also classified as mental disorders are eating disorders. 6 Anorexia and bulimia are eating disorders found primarily in women with estimated lifetime prevalence rates of 0.5% to 3.7% for anorexia and 1.1% to 4.2% for bulimia. 1 The World Health Organization (WHO) tracks years of healthy life lost because of disability or premature death across a wide variety of physical and mental disorders with a measure called the disability adjusted life year (DALY). 7 According to the WHO's most recent estimate, neuropsychiatric conditions were the cause of nearly 12.3 million DALYs in the United States in 2002. 7 Depression and anxiety disorders accounted for just over 5.7 million DALYs in the United States in the same year, with unipolar depression being the single greatest cause of DALYs across all physical and mental disorders. 7 In fact, unipolar depression was estimated by the WHO to be the fourth leading cause of DALYs in the world in 2002 and was projected to be the second leading cause by 2030 -second only to HIV/ AIDS. 8 In high-income countries, unipolar depression will be the number one cause of DALYs by 2030. 8 Given the enormous impact that depression, anxiety, and other mental disorders are estimated to have on disability and years of productive life lost, it should come as no surprise that these disorders create an enormous cost burden on employers. This cost burden is felt by American employers both in terms of dollars paid out for medical and pharmaceutical treatment of employees and dollars lost due to absenteeism, disability, and presenteeism. An overview of the literature on anxiety disorders reported the estimated annual cost in the Unites States to be between $42.3 billion and $46.6 billion, of which over 75% was attributed to indirect costs such as lost productivity. 5 Similarly, a study of adults diagnosed with ADHD found these patients had significantly higher total medical costs and workplace absences than a matched non-ADHD cohort, with almost 2.5 times the medical costs and 3.8 times the unofficial absence days. 6 Likewise, a study of the total direct and indirect costs of depression in employees of a major US corporation found that depressive illness was associated with a mean of 9.86 annual sick days, significantly more than any of the other conditions. 9 The study also found that total per capita direct and indirect costs for depression were approximately the same as the total costs for any other major illness. 9 The direct cost burden of depression, anxiety, and emotional disorders to employers in terms of dollars paid out for medical and pharmaceutical treatment of employees has been well documented. A retrospective study of depression and anxiety disorders in a large managed care population, demonstrated that patients with comorbid depression and anxiety disorders were far more likely to exhibit somatic complaints such as abdominal pain, chest pain, and fatigue-and to have prescriptions filled for narcotic analgesics, proton-pump inhibitors, and muscle relaxants-than a matched control group. 10 In addition, patients with comorbid diagnoses for depression and anxiety disorders exhibited significantly higher overall inpatient, emergency department, and outpatient utilization and costs than the control group. 10 Patients with a single diagnosis for either depression or anxiety also demonstrated significantly higher utilization and costs than the control group. 10 In addition, numerous studies have found a demonstrable link between chronic mental illness and high levels of emergency department utilization. 10 -13 For instance, a recent Kaiser Foundation study showed that patients with comorbid mental and physical chronic conditions were far more likely to be high utilizers of emergency departments than patients with no physical or mental conditions, with either of these conditions separately, or the general population at large.
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In addition to a direct cost burden for depression, anxiety, and emotional disorders in the workforce, employers also shoulder an indirect cost burden for dollars lost due to absenteeism, disability, and presenteeism. A review of the research on the impact of depression on employers concluded that direct medical expenses represent just the tip of the iceberg with regard to the cost burden of depression.
14 Similarly, data from the MacArthur Foundation's Midlife Development in the US Survey of working age adults revealed that persons with major depression, panic attacks, and generalized anxiety disorder missed an average of 4.3, 5.3, and 6.0 workdays, respectively, in the month prior due to absenteeism and presenteeism related to their disorder. 4 Finally, two recent studies of the impact of depression and comorbid conditions on workers found that depression was the largest single predictor of absenteeism 15 and reduced work performance 16 among any of the conditions examined-an effect that was exacerbated by the presence of comorbidities such as chronic pain, anxiety disorders, and fatigue-sleep disturbances. [15] [16] The first study-from a national Canadian epidemiologic survey-found that persons with a major depressive disorder were 2.9 times more likely to be absent from work than persons without such a disorder. 15 The second study, by Kessler et al, 16 linked Health and Work Performance Questionnaire data with medical-pharmacy claims data and found that depression had the largest individual level effect on work performance of any condition studied.
Methodological Issues in Estimating Disease Prevalence and Total Health Care Costs
As awareness of the economic burden of chronic disease in the workforce has grown there has been increasing employer interest in an integrated approach to managing human resource cost centers that were previously viewed as independent silos. 17 Numerous studies have identified various components of total health care costs from the perspective of the employer. 18 -23 These components include "direct" dollars paid out for the medical and pharmaceutical treatment of employee diseases, and "indirect" dollars lost due to absenteeism, presenteeism, short-term disability, long-term disability, family and medical leave (FML), worker's compensation, and turnover. 18 -23 Concurrent with increased research activity measuring total health care costs has been increased debate over appropriate methods for measuring such costs. 24 -26 A lack of consensus on a definitive approach for measuring total health care costs has led to confusion because cost estimates can vary widely depending on the research methodology used. 24, 27 A central issue in the methodological debate has been over whether the data used to estimate total health care costs should come from administrative sources such as medical claims and personnel records or from employee self-report via survey data. 24 Although some researchers have opted to measure these costs by relying entirely on administrative data sources, 28 -29 others have chosen to derive the majority of their total health care cost dollar estimates from employee self-report data. 17 With regard to the measurement of direct costs of disease-defined as dollars paid out for medical and pharmaceutical treatment of employeesit is important that an appropriate methodology be used to allocate these costs from claims data to individual employee disease conditions to avoid double counting by allocating the same costs to multiple diseases. 24 This allocation process requires the grouping of individual medical and pharmacy services together into discrete and clinically homogenous episodes. The measurement of employee disease prevalence can vary widely depending on the data source used. For instance, some survey instruments such as the Work and Health Interview and the Health and Work Performance Questionnaire assess not only lost productivity but also employee disease status and prevalence. 30, 31 However, wide variances in disease prevalence rates have been found when comparing administrative health care claims data and self-report data for the same population. 32 A validation study of health care claims and self-reported disease status found that claims data had significantly higher sensitivity in identifying disease status and that reliance on self-report resulted in underreporting of chronic illness rates. 32 Likewise, a similar study highlighted the importance of using both medical and pharmacy claims data for estimating disease prevalence by demonstrating that sensitivity and specificity for correctly identifying patients with hypertension were significantly higher when both claims data sources were used together. 33 Research on the indirect costs of disease to employers is known to be fraught with many methodological and measurement problems, particularly with regard to internal validity. 34, 35 These problems are compounded by the difficulty in obtaining administrative data and the frequent reliance by many researchers on data generated solely from self-report. 18 As a result, concomitant with the growing interest in measuring lost productivity and indirect costs of disease has come growing skepticism from researchers and corporate executives regarding the use of self-report surveys to measure such costs. 24, 26, 36 The measurement problem is exacerbated by the difficulties inherent in quantifying productivity-especially for white-collar workers-and the lack of data from many companies on illness related absenteeism. In addition, the basic methodological issue for measuring each of the components of indirect costs is not only one of accurately quantifying lost productive work time, but also assigning a monetary value to that lost time and validly attributing it to specific disease conditions. 37 Of all the indirect cost components, the least consensus exists for the measurement of presenteeism; however, there also exists significant disagreement as to how to measure and monetize absenteeism and disability. 37 As a result of the disagreement and uncertainty, many in the research community have urged caution when estimating the indirect costs of disease and called for ongoing development of better methods for making such estimates. 26 The reliance by many researchers on self-report data has been mainly due to the perception that administrative data are difficult to obtain rather than a preference for selfreport as a more valid method. 24 As a result, numerous self-report instruments have been developed and used for measurement of absenteeism, presenteeism, and other on-the-job impairment. 24,27,38 -40 A variety of methodological concerns have been raised in reviews of these instruments. Such concerns are heightened because of plausible alternative reasons for employee absenteeism and presenteeism apart from disease status. 26 For instance, research has demonstrated the existence of considerable cyclical and seasonal variations in absenteeism, with variation in absenteeism reliably related to year, season, and day of the week. [41] [42] [43] Other research has shown that the physical and psychosocial work environment has a significant impact on employee absenteeism and presenteeism apart from disease. [43] [44] [45] Likewise, personal factors such as stress and socioeconomic status have been found to impact employee absenteeism and presenteeism. 43, 46 Possibly, the most damaging form of bias for the estimation of indirect costs is recall bias. If accuracy is valued, a limited recall period of 2 weeks must be enforced, which provides a narrow window of opportunity for the collection of such data. 27, 38, 39 Stewart et al 27 in their study of the impact of recall period length on accuracy of employee reporting on lost productive time found that a 2-week recall period was optimal for minimizing reporting error and that a recall period of 4 weeks led to significant underreporting. A recent review by Mattke et al 38, 39 of 20 survey instruments measuring the impact of employee disease status on absenteeism and presenteeism cautioned about the validity and reliability of self-report data gleaned from surveys with greater than a 2-week recall period. In addition, recall bias, response bias, social desirability bias, and the Hawthorne Effect have been identified as critical methodological problems with using self-report survey data to measure absenteeism and presenteeism. 24 One of the greatest challenges in estimating indirect costs consists in accurately valuing the cost of lost employee labor time. In other words, how much value, measured in dollars, does an hour or day of a given employee's labor time contribute to the employer's production process? The answer to this question is complex, and little consensus currently prevails on the issue. 37 In 1992, a group of Dutch health economists called the "Erasmus Group" introduced the "Friction Cost Method" for valuing the cost of lost labor time. 47 The authors proposed a "friction period," determined by the length of the time it takes to fill an employee vacancy and restore former workforce production levels, to set an upper limit on the amount of unproductive time and indirect costs that can be attributed to any single illness episode. [47] [48] [49] [50] The Erasmus Group also argued that the monetization of any employee's lost labor time during the friction period should be based on that employee's total wage cost and the elasticity that exists between an employee's wage and the productive value of employee labor activity. 48 According to Pauly et al, 51 the extent of this elasticity is determined by three separate continuums on which a given employee's work unit falls: level of team production, cost of a substitute employee of equal ability, and severity of penalty for an output shortfall. This elasticity between wage and productive value can be expressed in terms of a wage multiplier. 52 So for instance, a wage multiplier of 1.25 would indicate the productive value of an employee's work time was 25% greater than the employee's wage. Further research by Nicholson et al 53 detected industry and occupation specific differences in the elasticity between employee productive value and wage. As might be expected, this elasticity was greatest in industries that relied on employees with highly specialized skills who had an immediate impact on customers and were difficult to replace. 53 As a result of this research, industryspecific wage multipliers were created that can be used with employee wages to determine the value of lost work time for a given employee in a given industry. 53 Another very recent study of presenteeism found that jobs with high-absenteeism wage multipliers also had high-presenteeism wage multipliers. 54 In light of methodological critiques of reliance on employee selfreport for quantifying indirect costs of disease, recent studies have emerged that use administrative data for estimation of these costs. 28, 29 A study by Wahlqvist et al, 28 used health care claims, benefit claims, and personnel data to quantify lost hours and days due to sick leave, presenteeism, short-and long-term disability, and worker's compensation among employees with gastroesophageal reflux disease. In addition, the authors used work output data collected electronically to measure presenteeism. 28 Similarly, a recent study of the direct and indirect costs of fibromyalgia likewise relied solely on administrative employee health care (medical and pharmacy) and disability claims data to calculate medical, pharmacy, disability, and absenteeism costs. 29 The authors not only used medical claims data to assess inpatient and outpatient medical costs but also used the documented hospital stay and doctor visit dates of service to infer workday absences for employees. 29 The methods used in these recent studies are actually an extension of methods used in earlier studies by Burton et al, 19 as well as by Birnbaum and Barnett, [55] [56] [57] who used administrative data to estimate the indirect costs of cancer, arthritis, asthma, and health lifestyle risks in multiple employee populations. All of these studies have demonstrated the validity and practical utility of research methods for calculating the direct and indirect costs of disease that rely on administrative data.
Research Objectives
The objective of our research was to conduct an employer case study to quantify the direct and indirect cost burden of employee depression, anxiety, and emotional disorders. An additional research objective was to use administrative data sources and develop replicable methods for quantifying direct and indirect costs of disease.
Materials and Methods

Participants
The study population consisted of 4031 active employees of a large insurance company primarily located in the southeastern United States. Only active employees from calendar year 2004 who chose to opt into the employer's group medical benefit plan were included. Insured dependents of employees, as well as retirees, were excluded from the study. Medical and pharmacy claims-as well as personnel, productivity, and benefits data-from 2004 were obtained from the company's human resources division and merged at the individual employee level. A third party was used to blind and merge the data to protect the privacy of individual employees. In addition, the study proposal was evaluated by an Internal Review Board and received approval before commencement.
Measures
Description of Independent Variable. The independent variable was the broad disease category of depression, anxiety, and emotional disorders, and consisted of the 11 Episode Treatment Groups (ETGs) outlined in Table 1 .
Description of Dependent Variable. The dependent variable consisted of two broad components: the direct and indirect costs of disease. Direct costs were defined as allowed dollars paid for medical treatment of employees and encompassed three broad service categories: inpatient, professional/outpatient, and pharmacy. Inpatient costs were those costs directly associated with a hospital admission. These included charges for facility, room-and-board, 24-hour care, and other items provided by the hospital (such as pharmaceuticals and disposable medical products). Professional/outpatient services were those associated with outpatient hospital services, professional services provided during a hospital stay (eg, surgery), professional services provided at a provider's office or other outpatient setting, and ancillary services provided by ancillary providers. Pharmacy services were those associated with prescription drugs, including high-cost injectables and specialty pharmaceuticals. Indirect costs were defined as labor resources lost by the employer due to employee illness and comprised five categories: absenteeism, presenteeism, short-and long-term disability, and FML. Absenteeism was defined as hours absent from work for health reasons and presenteeism was similarly defined as unproductive hours while present at work. Short-and long-term disabilities were identified in terms of dollars paid out for employee disability claims, and FML was identified as approved FML absence days. Table 1 were then grouped into the higher-level category of depression, anxiety, and emotional disorders.
Direct Costs. Individual line item information from 2004 was extracted from health care claims data and put into the appropriate direct cost categoryinpatient, professional/outpatient, or pharmacy-using the MCSource data tool. In addition, each service and its associated allowed dollar amount were identified and classified into a discrete ETG category. This procedure insured that dollars attributed to depression, anxiety, and emotional disorders were not "double-counted" and attributed to other disease conditions as well. A summary description of the direct cost components and measurement methods is provided in Table 2 .
Indirect Costs. The five indirect cost components of absenteeism, presenteeism, short-term disability, long-term disability, and FML were all measured using administrative data sources. A summary description of the indirect cost components and measurement methods is provided in Table 3 . Using a method previously employed by Birnbaum and Barnett, 55, 56 absenteeism was calculated in hours on the basis of inpatient and outpatient workday dates of service taken from employee medical claims. Each inpatient day counted as 8 hours and each outpatient visit counted as 4 hours. A rule was established that employees could not incur more than 4 hours in absenteeism for outpatient visits in a day. This method had the advantage of being applicable to employees from the study population who recorded both sick and vacation days as "Paid Time Off (PTO)." To convert lost absenteeism hours into indirect cost dollars, employee hourly wage costs (including the cost of employee benefits) taken from personnel records of pay grade midpoints were multiplied by hours absent and then by a wage multiplier of 1.41. The wage multiplier of 1.41 represented the average excess value that insurance industry employees produce over and above their hourly wage. 52, 53 Finally, relative weights were created based on diseasespecific population averages and individual comorbidity burden, and used to attribute absenteeism hours and dollars to specific diseases for each employee. This method prevented double counting by insuring that the same absenteeism hours and dollars were not attributed to more than one disease for employees with multiple disease conditions. FML was measured on the basis of approved FML absences taken from employee personnel records. For each FML occurrence, there was a record of workdays missed while on FML; these FML days were converted into missed hours of work time using an 8-hour workday as the time unit. Although FML is unpaid leave, it was still deemed to be an expense due to the elasticity between wage and value represented by the wage multiplier of 1.41, and due to 
Psychiatric disease signs and symptoms the fact that employees continued to receive benefits while on FML. Thus, FML hours were converted into indirect cost dollars by multiplying employee hourly wage costs (including the cost of employee benefits) by the wage multiplier of 1.41 Ϫ 1. This insured that only an employee's hourly value exceeding the wage cost was counted. Finally, FML dollars were then attributed to specific diseases by applying the same relative weighting methodology used to attribute absenteeism dollars to specific disease conditions. Short-and long-term disability were measured from documented claims reported by the employer's disability vendor at the individual employee level of analysis. Unfortunately, the vendor did not provide a record of employee workdays on disability but only total dollars paid out per claim. As a result, the wage multiplier of 1.41 was not used to calculate the excess value of lost work time above the hourly wage. In addition, the vendor did not provide data that linked individual disability claims to specific disease conditions. However, it was possible to attribute short-and long-term disability claim dollars to specific diseases by using the same relative weighting method that was used to attribute absenteeism and FML dollars to specific diseases.
Presenteeism was estimated directly for customer service employees from available productivity data; however, for white-collar employees, an indirect proxy estimate of annual salary merit raise was used to estimate presenteeism. The study population was reduced by 14.5% for the measurement of presenteeism because employees who were newly hired or terminated were excluded because they did not have enough tenure for a salary raise, were still in training, or were in pay grades not conducive to a relative raise performance analysis. In addition, white-collar employees who were not continuously employed for 12 months in 2004 were excluded because they would poten- were added because we were uncertain as to actual days absent from work. Disability dollars were attributed to specific disease conditions using relative weights based on disease-specific population averages and individual comorbidity burden. This prevented attribution of the same costs to more than one disease for employees with multiple disease conditions.
The disability vendor did not include data that linked individual disability claims to specific disease conditions, so we employed the method we used for absenteeism and FML disease attribution.
Family and Medical Leave (FML)
Any recorded absences for family and medical leave. Each FML occurrence for each employee had a record of work-days missed on FML. These FML days were converted into missed hours of work time.
Multiplied employee total wage cost (including benefits) by FML hours and then by the wage multiplier of 1.41-1 (FML is unpaid leave so only the hourly value exceeding wage cost was counted). Lost hours/dollars were attributed to specific disease conditions using relative weights based on disease-specific population averages and individual comorbidity burden. This prevented attribution of the same costs to more than one disease for employees with multiple disease conditions.
Even though FML is unpaid leave it is still deemed to be an expense due to the elasticity between wage and value represented by the (insurance industry specific) wage multiplier of 1.41.
tially be missing annual salary raise data.
Customer service employees comprised 21% of the employee population for whom presenteeism was estimated. These employees worked at a call center and were given productivity scores for "on-call" times that were then converted into productive and unproductive hours on a biweekly basis. The total number of each employee's unproductive hours during the year was estimated by applying the "on-call" productivity score to all hours worked. To adequately differentiate between unproductive employees and the rest of their peers, the lower 25th percentile for productivity scores was used as a cutoff to identify unproductive employees. This approach was successfully implemented in a previous study of call center employees. 19 An unproductive ratio was created for these employees that represented the percent of their total hours worked that were unproductive. All employees above the 25th percentile cutoff were assigned an unproductive ratio equal to zero. The unproductive ratio was then used as the dependent variable in an ordinary least squares (OLS) regression model that included age, gender, and disease conditions as independent variables to determine the impact of multiple disease conditions on productivity. A backwards elimination model was used with individual variable significance level stay (slstay) set at P Յ0.25. For those disease condition variables that remained in the significant model (P Յ 0.05), the parameter estimates were used to calculate the proportion of unproductive hours that were attributable to disease for each disease category. The parameter estimates represented the fraction of a diseased employee's unproductive hours that were attributable to the particular disease in question. Age and gender were included in the model regardless of significance level and used to risk adjust the impact of disease conditions on productivity. Unproductive hours were then converted into presenteeism dollars by applying the same methodology used to convert absenteeism hours to dollars.
White-collar office employees comprised the other 79% of the employee population for whom presenteeism was estimated. Because of the fact that neither productivity nor performance scores were available for this class of employees, annual percent salary raise was used as a proxy for performance. A relative performance score was calculated for employees on the basis of how their annual raise percent compared with that of their exempt or nonexempt peers. This relative performance score was then converted into an unproductive ratio for employees in the lower 25th percentile that represented the percent of their total hours worked that were unproductive. To be conservative, a ceiling of 0.50 was established for the unproductive ratio so that a minimum level of productive hours was counted for those employees whose raise percent was very low. All employees above the 25th percentile cutoff were assigned an unproductive ratio equal to zero. The unproductive ratio was again used as the dependent variable in an OLS regression model that included the same variables as the regression model used for the call center employees. Likewise, the same process was used for applying parameter estimates to calculate the proportion of unproductive whitecollar hours that were attributable to disease for each disease category. These unproductive hours were then converted into presenteeism dollars by applying the same methodology used to convert absenteeism hours to dollars.
Total Health Care Costs and Productivity Ratios
Finally, direct and indirect cost components were summed to arrive at the total health care cost dollar estimate for depression, anxiety, and emotional disorders in the employee population. In addition, the impact of these costs on the company's overall productivity and revenues in 2004 was also estimated. Total revenue lost per full time equivalent (FTE) employee was estimated as the difference between actual revenue produced in 2004 per FTE and the potential revenue produced per FTE had there been no direct or indirect costs incurred by the employer due to depression, anxiety, and emotional disorders in employees. Potential revenue produced per FTE was estimated to be equal to total revenue divided by total FTEs after subtracting the direct and indirect costs of depression, anxiety, and emotional disorders from total payroll costs. On the basis of this financial analysis, three scenarios demonstrating the impact of 10%, 20%, and 30% total health care cost reductions on total corporate revenues in 2004 were simulated.
Results
Population Demographics and Condition Prevalence
An overview of some selected demographic statistics in the employee population is provided in Table 4 . As can be seen, the population was almost 80% female, and the median age was approximately 38. In addition, the vast majority of employees were full-time workers that opted into the employer's group medical benefit. The study population was limited to those employees that opted into the medical benefit. A total of 464 employees from the study population were identified as having depression, anxiety, or emotional disorders-a prevalence rate of 11.5%. Figure 1 displays the direct medical costs of depression, anxiety, and emotional disorders in the employee study population. The total costs were $358,978, with 59% of the costs coming from pharmacy utilization, 40% from professional and outpatient visits, and 1% from inpatient stays. The mean annual direct costs attributable to depression, anxiety, and emotional disorders per employee with the condition were $774, and the mean costs per employeedistributed across the entire workforcewere $89.
Direct and Indirect Cost Components
The indirect costs of employee depression, anxiety, and emotional disorders can be seen in Fig. 2 . These costs were a total of $404,782, which are equivalent to an annual average of $872 per employee with the condition and $100 per employee across the entire workforce. Absenteeism accounted for 57% of these indirect costs; 28% were attributable to presenteeism, 9% to FML absences, and 6% to short-term disability. There were no long-term disability costs attributable to depression, anxiety, and emotional disorders in this population. In terms of employee work hours lost, there were a total of 12,272 productive hours lost-in the form of absenteeism, presenteeism, or FML-that were attributable to depression, anxiety, and emotional disorders. (No time lost could be calculated for short-term disability because this was not reported by the vendor.) This loss of productive work time equaled roughly 3.3 days per employee with the condition per year and 3 hours per employee spread across the entire workforce.
A special note should be made about the difficulty encountered in attributing presenteeism hours for white-collar and customer service employees to particular disease conditions. Although a large number of presenteeism hours were quantified, only a small proportion of these were found to be attributable to any disease. This may have reflected the reality that many lost work hours due to unproductive time were attributable to personal and environmental factors apart from employee disease. Of the total 478,572 presenteeism hours quantified for employees in this study in 2004, 6.6% of these were attributed to specific diseases. In addition, not all disease categories were found to be significant in the OLS regression models. For the depression, anxiety, and emotional disorders category, only the OLS regression model for white-collar employees-and not the model for customer service employees-was able to detect an impact on productivity and attribute presenteeism hours accordingly. According to the parameter estimates from the modelfor these employees with depression, anxiety, and emotional disordersapproximately 1.7% of their unproductive time was attributable to their condition.
Overall Impact
The total direct and indirect costs attributable to depression, anxiety, and emotional disorders in this employee population are displayed in Fig. 3 . The total costs were $763,760, with 47% coming from direct costs and 53% coming from indirect costs. The mean annual total health care costs attributable to depression, anxiety, and emotional disorders per employee with the condition were $1646, and the mean costs per employee-distributed across the entire workforce-were $189. The largest cost areas were absentee- ism, pharmacy utilization, professional and outpatient visits, and presenteeism-in that order. It should be noted that the $1646 average price tag per employee with the condition does not represent the total health care costs incurred by those employees. Rather, the price tag represents those costs that were specifically attributable to the presence of depression, anxiety, and emotional disorders in employees with the condition. In most cases, employees had additional costs that were attributable to additional conditions. Finally, depression, anxiety, and emotional disorders were the fifth costliest of all disease conditions-from a total cost perspective-across the entire employee population. The total cost of these disorders was higher than that of any of the traditional "disease management five" of coronary artery disease, diabetes, asthma, chronic obstructive pulmonary disease, or congestive heart failure.
On the basis of actual corporate revenue produced per FTE in 2004 and the additional labor capital costs created by the direct and indirect costs of employee depression, anxiety, and emotional disorders, it was estimated that $1823 in potential revenue per FTE was lost by the employer due to this condition. In other words, if there were no direct or indirect costs borne by the employer due to depression, anxiety, and emo- Figure  4 demonstrates the large dollar impact-between $0.75 million and $2.25 million-that such reductions in total health care costs would have had on total corporate revenues.
Discussion
Conclusions
This employer case study verified and quantified the existence of direct and indirect costs attributable to depression, anxiety, and emotional disorders in the employee study population. In concordance with findings from prior research, our results demonstrated that the cost burden of these disorders was among the greatest of any of the disease conditions in the employee population. 9, 58 The inclusion of indirect costs in the study demonstrated that for every 47 cents spent by the employer on direct medical and pharmacy costs for employees, an additional 53 cents were lost due to employee absenteeism, presenteeism, FML, and short-term disability. This provided the employer with a more accurate and informed picture of the relative cost burden of employee depression, anxiety, and emotional disorders that would have otherwise been obscured by a view that only included direct medical costs. An analysis of the impact of these total costs on the relationship between the employer's labor inputs and revenue outputs demonstrated a large productivity loss in terms of revenues produced per FTE across the entire workforce. This productivity loss resulted in over $7.5 million in revenues foregone by the employer in 1 calendar year. As the simulated financial scenarios illustrated, an employee intervention that produced moderate reductions in total health care costs for depression, anxiety, and emotional disorders could have had a large impact in regaining a portion of these foregone revenues.
The integration of administrative personnel and benefits data with health care claims data at the individual employee level made it possible to estimate what proportion of employee direct and indirect costs were specifically attributable to depression, anxiety, and emotional disorders and not to other disease conditions or factors. Employment of this design provided several important advantages that demonstrate the utility of relying on administrative data sources to quantify the direct and indirect costs of disease rather than employee self-report. First, the use of health care claims data with the episode of care grouper ensured that the same direct cost dollars were not allocated to multiple conditions and double or triple counted. Second, the use of episodes of care to identify disease status enabled us to verify that employees identified with depression, anxiety, and emotional disorders in fact had been diagnosed with those conditions. Such verification would not have been possible if we had relied on employees to selfreport their disease status. Third, the integration of administrative data at the individual level enabled a method for isolating those indirect costs that were uniquely attributable to employee depression, anxiety, and emotional disorders. The problem of attribution is notoriously difficult because of the many factors apart from disease status-such as personal motivation, organizational factors, or seasonality-that influence absenteeism and work productivity. [41] [42] [43] [44] [45] [46] Disentangling the influence of potential confounders was made possible in this study by individual-level data integration that enabled statistical inferences to be drawn regarding the proportion of indirect costs attributable to disease status. As was demonstrated in the case of presenteeism, a significant proportion of these costs could not be attributed to any disease conditions. However, the application of regression models enabled us to establish that some proportion of presenteeism costs was attributable to employee disease status. In addition, the identification of absenteeism on the basis of medical dates of service solved the attribution problem in a more straightforward fashion by verifying that all absenteeism was in fact related to medical treatment for disease. Finally, the benefit offered from the administrative data sources derived from the fact that these data sources were already used and trusted by decision makers for other business purposes. Such a benefit offered significant advantages when disseminating findings regarding indirect costs to executives in the corporate boardroom.
It should be noted that the friction cost method was used to value the cost of lost employee labor time instead of the human capital approach. Where the human capital approach would result in attribution of all potential future indirect costs to the employer should an employee go on permanent disability or die, the friction cost method sets an upper limit on indirect costs attributable to the employer based on the estimated length of time it would take to find a permanent replacement employee. 47 Although from a societal perspective the human capital approach may more accurately value the cost of lost labor productivity due to disease over many years, the same is not true when attributing the cost of lost labor productivity to a given employer in a limited time period. Thus, only those employees with a record of health care benefits and payroll enrollment in calendar year 2004 were included in the study population. Absenteeism episodes were capped at 5 consecutive days because the employer's short-term disability benefits initiated employee wage replacement after that point. Both short-term disability and FML costs were calculated without a cap because these benefits were time limited and would not have resulted in the permanent replacement of an employee. Finally, as was already noted, the company did not bear any long-term disability costs related to depression, anxiety, and emotional disorders in 2004.
Limitations
Several important limitations should be acknowledged. First, given the reality that the population was 80% female, most of whom lived in the southeastern United States, our findings may not be generalizable to other employee populations. Second, it is likely that our absenteeism estimates were conservative because employee absences that did not result in a record of a provider office visit or inpatient stay were not counted. The advantage of this approach despite this limitation, however, was that all absences could be linked to a medical reason and the lack of differentiation between vacation time and sick leave by the employer was not fatal to our study. Third, it is likely that employee short-term disability cost estimates were underreported because the data provided by the disability vendor did not include days absent for employees but only dollars paid out per claim. As a result, the additional costs of employee absence factored by the wage multiplier were not counted. Fourth, in light of the small proportion of presenteeism that was attributed to any employee disease-and to depression, anxiety, and emotional disorders in particular-a question may be raised as to the explanatory power of the regression model used to attribute presenteeism hours to disease status. Although prior research has demonstrated the existence of personal and environmental factors that influence employee presenteeism apart from disease status, 43, 45 it seems unlikely that only 6.6% of presenteeism hours-the amount detected in this study-were attributable to any employee disease. Perhaps, the inclusion of additional variables would have added explanatory power to our regression model. At the same time, it is also true that the investigation of these difficult attributional questions would not have been possible were it not for the integration of individual-level health care claims data with employee performance and salary data. It is true that our model left much variance unexplained; nonetheless, it is a significant accomplishment to have been able to attribute 1.7% of the unproductive hours of white collar employees with depression, anxiety, and emotional disorders to their disease condition. It should also be acknowledged as a limitation that untreated employee medical conditions went undetected due to the lack of recorded diagnoses in employee medical claims. This may have resulted in underreporting of the prevalence rate for employee depression, anxiety, and emotional disorders. (This may also point to the utility of integrating administrative data sources with self-reported data in the future.) For example, the National Comorbidity Survey Replication found a 12-month prevalence rate of 19.8% for adults with anxiety, mood, and impulse control disorders (including depression and ADHD) when substance disorders and bipolar disorders are removed from the estimate. 2 Assuming this national prevalence rate of 19.8% were true for the study population-as opposed to the 11.5% prevalence rate detected from health care claims data-a total of 798 employees had depression, anxiety, and emotional disorders in 2004. In other words, approximately 334 employees from the total study population had undiagnosed and untreated depression, anxiety, and emotional disorders in 2004. Unfortunately, we had no way of identifying these employees in the study population and therefore are unable to quantify their impact on costs. If we were to assume similar indirect costs for these employees as their counterparts, however, we could extrapolate an additional indirect cost burden of $291,248 to the employer in 2004.
The issue of latent or untreated depression, anxiety, and emotional disorders in employees not only begs the question of what the cost burden was for nontreatment, but it also begs the question of what the cost burden was for appropriate versus inappropriate treatment. Although this issue was not the subject of this particular study, it is certainly a topic worthy of further research in the future. Such research should examine how individual employee treatment plans for depression, anxiety, and emotional disorders compare with the latest evidence-based guidelines. Deviations from these guidelines-gaps in care-could then be identified and tested to determine what impact such gaps might have on direct and indirect costs of disease to employers. Adherence to antidepressant medication therapy, for instance, has been shown to be related to direct medical claims cost savings. 59, 60 In addition, primary care depression management has been found to have a positive impact on reducing employee absenteeism and improving productivity. 61 Such studies point to the hypothesis that adherence to evidence-based care for depression, anxiety, and emotional disorders is related to positive direct and indirect cost outcomes for employers.
Implications
Given the high-relative cost of employee depression, anxiety, and emotional disorders in terms of direct and indirect costs, as well as in revenues foregone, it may be in many employers' best interests to invest in programs that address and manage these disorders. It is informative that the total cost of these disorders was higher than that of any of the traditional "disease management five" in the employee population. Such a finding may cause employers to rethink the allocation of disease management resources as part of an overall workforce health management strategy. It may also be beneficial for employers to consider whether there might be environmental and organizational factors that exacerbate or interact with employee depression, anxiety, and emotional disorders that can be addressed. Finally, given the high prevalence of these disorders in the United States, 2,3 the findings of this study might have more general implications for population health management strategies in workforces although out the country.
Employers and executive decision makers intuitively know that indirectas well as direct-costs exist in their workforces and result in the loss of a large amount of money due to lost employee time and productivity. This is true for conditions such as depression, anxiety, and emotional disorders. At the same time, it has been difficult to "sell" employers on the validity of specific cost estimates that include indirect costs as a component. These conflicting realities are explained by the fact that indirect costs are relatively difficult to verify and decision makers are apprehensive of acting upon estimates that are reliant solely on employee selfreport. 24, 26, 36 As a result, it may be worth considering alternative methods for quantifying these costs that are based on available administrative data sources decision-makers trust. This case study has demonstrated the possibility and utility of such methods. Although it will be argued that our methodology resulted in an overly conservative estimate of indirect costs, we would counter by positing that a cautious approach requiring corroboration from administrative data seems prudent at this point in time because it is verifiable to employers.
